TARDIS trial seeks new dimension in stroke treatment

October 17, 2011 in Cardiology

People who suffer from acute stroke or Transient Ischaemic Attack (TIA, a mini stroke) could get better treatment in the future thanks to the expansion of a large clinical trial of a new combination of drugs led by researchers at The University of Nottingham.

The TARDIS trial is testing the safety, tolerability and effectiveness of an intensive blood thinning therapy involving a combination of three drugs instead of the one or two that are normally prescribed.

The scientists have recruited more than 550 patients with stroke or TIA from across the UK but now hope to expand the trial to include up to 4,200 patients from around the world. They believe that by using three anti-platelet drugs (the combination of aspirin, clopidogrel and ) instead of the one or two currently used now, the effects of the stroke and chances of recurrence could be greatly reduced.

Strokes happen when the blood supply to part of the brain is cut off by a blood clot or other blockage. Around 150,000 people have a stroke in the UK every year. Stroke patients occupy a fifth of acute hospital beds and a quarter of long-term beds. For about a third of the the attack proves fatal and many more are left severely disabled.

TARDIS stands for Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke. The trial is a randomised, parallel-group in which, within 48 hours of a stroke or TIA, half the patients recruited are given the 3-drug combination for one month. The other half receives the existing guideline antiplatelet therapy. Both groups are monitored for 90 days for frequency and severity of by observers who do not know which treatment the patient has been on.

The major risk of taking an extra antiplatelet drug is the possibility of causing extra bleeding, such as bruising on the skin, into the gut or bleeding into the brain. But the scientists believe the potential benefit of a reduced chance of having another stroke will outweigh the risk of further bleeding.

Chief investigator, Professor Philip Bath from the University’s School of Clinical Sciences said: “We believe this trial will be hugely significant in finding a better treatment for stroke and TIA to minimise the effects and the risk of recurrence in . We are going to be able to compare the frequency and severity of recurrent cerebrovascular events in both sets of patients; data which will be invaluable in stroke medicine worldwide.”

The initial UK phase of the TARDIS trial has been funded by the British Heart Foundation through the University’s Division of Stroke Medicine. Now the researchers are seeking funding to expand the trial to include 4,200 new patients from across the world over the next five years.

Provided by University of Nottingham search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Free fatty acids linked to cardiac risk in late adulthood

(HealthDay)—Blood levels of free fatty acids are associated with insulin resistance during young adulthood and cardiovascular risk factors in later adulthood, according to a study published online May 13 ...

Cardiology created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Diagnosing heart attacks: There's an app for that

An experimental, inexpensive iPhone application transmitted diagnostic heart images faster and more reliably than emailing photo images, according to a research study presented at the American Heart Association's Quality ...

Cardiology created May 17, 2013 | popularity not rated yet | comments 0

Study suggests new role for ECMO in treating patients with cardiac arrest and profound shock

Extracorporeal membrane oxygenation (ECMO), a procedure traditionally used during cardiac surgeries and in the ICU that functions as an artificial replacement for a patient's heart and lungs, has also been used to resuscitate ...

Cardiology created May 17, 2013 | popularity not rated yet | comments 0

Stroke patients respond similarly to after-stroke care, despite age difference

Age has little to do with how patients should be treated after suffering a stroke, according to new research from the University of Georgia.

Cardiology created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast

Depression linked to almost doubled stroke risk in middle-aged women

Depressed middle-aged women have almost double the risk of having a stroke, according to research published in Stroke: Journal of the American Heart Association.

Cardiology created May 16, 2013 | popularity not rated yet | comments 0


New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

New colonoscope provides ground-breaking view of colon

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...